sapacitabine Search Results


sapacitabine  (MedChemExpress)
90
MedChemExpress sapacitabine
(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and <t>Sapacitabine</t> (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.
Sapacitabine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapacitabine/product/MedChemExpress
Average 90 stars, based on 1 article reviews
sapacitabine - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
sapacitabine  (Cyclacel Inc)
90
Cyclacel Inc sapacitabine
(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and <t>Sapacitabine</t> (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.
Sapacitabine, supplied by Cyclacel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapacitabine/product/Cyclacel Inc
Average 90 stars, based on 1 article reviews
sapacitabine - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
dosage regimen for sapacitabine and seliciclib  (Cyclacel Inc)
90
Cyclacel Inc dosage regimen for sapacitabine and seliciclib
(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and <t>Sapacitabine</t> (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.
Dosage Regimen For Sapacitabine And Seliciclib, supplied by Cyclacel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dosage regimen for sapacitabine and seliciclib/product/Cyclacel Inc
Average 90 stars, based on 1 article reviews
dosage regimen for sapacitabine and seliciclib - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
chemicals sapacitabine  (Daiichi Sankyo)
90
Daiichi Sankyo chemicals sapacitabine
(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and <t>Sapacitabine</t> (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.
Chemicals Sapacitabine, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chemicals sapacitabine/product/Daiichi Sankyo
Average 90 stars, based on 1 article reviews
chemicals sapacitabine - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
sapacitabine (cyclacel bl) formulation capsule  (Cyclacel Inc)
90
Cyclacel Inc sapacitabine (cyclacel bl) formulation capsule
(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and <t>Sapacitabine</t> (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.
Sapacitabine (Cyclacel Bl) Formulation Capsule, supplied by Cyclacel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapacitabine (cyclacel bl) formulation capsule/product/Cyclacel Inc
Average 90 stars, based on 1 article reviews
sapacitabine (cyclacel bl) formulation capsule - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
sapacitabine 25  (Cyclacel Inc)
90
Cyclacel Inc sapacitabine 25
(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and <t>Sapacitabine</t> (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.
Sapacitabine 25, supplied by Cyclacel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapacitabine 25/product/Cyclacel Inc
Average 90 stars, based on 1 article reviews
sapacitabine 25 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
sapacitabine  (Adooq Bioscience LLC)
90
Adooq Bioscience LLC sapacitabine
(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and <t>Sapacitabine</t> (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.
Sapacitabine, supplied by Adooq Bioscience LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapacitabine/product/Adooq Bioscience LLC
Average 90 stars, based on 1 article reviews
sapacitabine - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
liquid fill formulations for sapacitabine  (Cyclacel Inc)
90
Cyclacel Inc liquid fill formulations for sapacitabine
(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and <t>Sapacitabine</t> (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.
Liquid Fill Formulations For Sapacitabine, supplied by Cyclacel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/liquid fill formulations for sapacitabine/product/Cyclacel Inc
Average 90 stars, based on 1 article reviews
liquid fill formulations for sapacitabine - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
sapacitabine cyc682 cs-682  (Daiichi Sankyo)
90
Daiichi Sankyo sapacitabine cyc682 cs-682
(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and <t>Sapacitabine</t> (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.
Sapacitabine Cyc682 Cs 682, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapacitabine cyc682 cs-682/product/Daiichi Sankyo
Average 90 stars, based on 1 article reviews
sapacitabine cyc682 cs-682 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
sapacitabine 2'-cyano-2'-deoxyarabinofuranosylcytosine  (Cyclacel Inc)
90
Cyclacel Inc sapacitabine 2'-cyano-2'-deoxyarabinofuranosylcytosine
(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and <t>Sapacitabine</t> (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.
Sapacitabine 2' Cyano 2' Deoxyarabinofuranosylcytosine, supplied by Cyclacel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapacitabine 2'-cyano-2'-deoxyarabinofuranosylcytosine/product/Cyclacel Inc
Average 90 stars, based on 1 article reviews
sapacitabine 2'-cyano-2'-deoxyarabinofuranosylcytosine - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and Sapacitabine (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.

Journal: bioRxiv

Article Title: Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells

doi: 10.1101/2021.07.19.452885

Figure Lengend Snippet: (A) Schematic illustrations of the establishment of CNDAC-resistant HL-60 and PL-21 cells by step-wise increasing drug concentrations during cell culture and of the establishment of single cell-derived clones by limited dilution. Moreover, representative Western blots indicating SAMHD1 and DCK levels in CNDAC-adapted HL-60 (HL-60 r CNDACI-XII) and PL21 (PL21 r CNDACI-XII) sublines and in single cell-derived clonal sublines of these cell lines. GAPDH and β-Actin served as loading controls. (B) Resistance profiles of CNDAC-adapted HL-60 and PL-21 sublines and single cell-derived clones of HL-60 and PL-21. Upper spider webs show sensitivity to the cytotoxic drugs CNDAC, 6-Thioguanine (6-TG), Clofarabine (CLOF), Cladribine (CLAD), Fludarabine (FLU), Gemcitabine (GEM), Decitabine (DAC), 5-Azacytidine (AZA), Daunorubicin (DAU), Cytarabine (ARA-C), and Sapacitabine (SAP), while lower spider webs display sensitivity to the targeted drugs Vismodegib (VISMO), Olaparib (OLA), Ganetespib (GANE), Gedatolisib (GEDA), Volasertib (VOLA), Molibresib (MOLI), and Venetoclax (VENE). Values are depicted as fold changes in drug concentrations that reduce cell viability by 50% (IC 50 s) between the respective parental AML cell line (shown in red) and the resistant cell lines or clones. Points closer to the centre than red lines indicate higher sensitivity to drugs in CNDAC-resistant sublines or clonal sublines than in parental cell lines, while points lying outside red lines indicate reduced sensitivity to the respective drug. IC 50 fold changes are shown as means from three independent experiments. Numerical values are provided in Supplementary Table 6.

Article Snippet: CNDAC was purchased from biorbyt (via Biozol, Eching, Germany), 5-azacytidine, cytarabine, cladribine, clofarabine, decitabine, and fludarabine from Tocris Biosciences (via Bio-Techne GmbH, Wiesbaden, Germany), 6-thioguanine, ganetespib, molibresib, olaparib, sapacitabine, venetoclax, and vismodegib from MedChemExpress (via Hycultec, Beutelsbach, Germany), daunorubicin, gedatolisib, and volasertib from Selleckchem (Berlin, Germany), gemcitabine from Hexal (Holzkirchen, Germany), GTP and dATP from Thermo Scientific (Dreieich, Germany), and CNDAC-TP from Jena Bioscience GmbH (Jena, Germany).

Techniques: Cell Culture, Derivative Assay, Clone Assay, Western Blot